chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Presented to ER on 11/30 with worsening shortness of breath, cough for 7 days. Oxygen saturation was 88% was placed on nasal cannula oxygen. Vaccinated for COVID in February 2021. COVID tested positive 11/30/2021. Admitted on 11/30/21. Placed on azithromycin, ceftriaxone, dexamethasone, and remdesivir. O2 requirements increased to 5L NC, ID and pulmonary consulted. O2 requirements increased again overnight 12/1/12/2, transferred to ICU. o2 requirements continued to increase, placed on Opti flow and then CPAP. Patient decided 12/4 am that he wanted to pursue comfort measures. Patient only required 2 L oxygen now and comfortable with oral and IV morphine, Ativan. Discharged on 12/9/21.
Severe vertigo/dizziness within half hour of vaccine lasting the rest of the evening with nausea.  The next day, light vertigo/dizziness all day on Friday, October 6th.  I still feel a hint of vertigo/dizziness on Saturday, October 7th.  The nausea went away after the first evening of the 5th.  I was shocked at how quick and fast the vertigo/dizziness hit me after the vaccine on Thursday, October 5th.  I had been at a field trip with kids to a pumpkin patch all day and nothing was wrong.  No hint of anything.  As soon as I got the vaccine, within a half hour, I was literally running into walls and almost falling over.  I even tried to take a nap to curb the effects to no avail.
12/01/2003: 50-60 papular rash with blisters reported by childs mother.  Sibling had been seen in office earlier for same symptoms.
1 hour post vax, the pt experienced hives from head to toe, mostly on trunk. The pt also experienced swollen eyelids the next day. The hives lasted 1.5 weeks.
Developed fever 102.4 last night and rash on abdomen, neck, back and buttocks. Mother gave motrin and tylenol per pcp's instructions. Taking to pcp today.
Pt came to ER, said she received first Moderna dose on 8/13/21 and she is not feeling well, head congestion, body aches.
severe muscle spasm, pain, weakness in lt arm, & base of skull stiff neck; APAP w/Codeine, Dolobid, Parafon forte; Ultra sound heat treatment-neck placed in a collar for whiplash-like sx; pain & inability to sleep on lt side-turn head cont;
This case involves an unknown age and unknown gender patient who experienced flu while receiving vaccine INFLUENZA VACCINE. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot (form, strength, dose, frequency, route, lot number, expiry date unknown) in unknown administration site as prophylactic vaccination. On an unknown date the patient developed a non-serious flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE. Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable. It was not reported if the patient received a corrective treatment for the event (flu). At time of reporting, the outcome was Unknown for the event flu.
This spontaneous report as received from a Medical Assistant refers to a patient of unknown age and gender. On 04-AUG-2015, the patient was vaccinated with a dose of improperly stored VARIVAX (Merck) lot # L000454, expiry date 06-JAN-2017 (route and dose were not provided). No adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
swellling; redness; firmness; warmth; injection site pain; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th January 2020, the patient received Shingrix (intramuscular). On 13th January 2020, immediately after receiving Shingrix, the patient experienced injection site pain. On 15th January 2020, the patient experienced swelling, erythema, induration and feeling of warmth. The patient was treated with non-drug therapy (Ice Pack (No Medication)). On an unknown date, the outcome of the injection site pain, swelling, erythema, induration and feeling of warmth were recovering/resolving.   It was unknown if the reporter considered the injection site pain, swelling, erythema, induration and feeling of warmth to be related to Shingrix.  Additional details were provided as follows: The patient experienced injection site pain as the dose was being administered. Two days after receiving vaccination, the Wednesday night the patient developed swelling 3 inches below the injection site along with redness, firmness and warmth. She put ice on the area and the area was going down a little as of this morning. The reporter consented to follow up.
Dizziness; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Apr2021 at 09:30 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history included thyroid disorder (thyroid problem) . Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine sodium (SYNTHROID) for an unknown indication, from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: UNKNOWN) via an unspecified route of administration, on an unknown date, (at the age of 64-year-old) as a single dose for COVID-19 immunisation. On 21Apr2021, the patient experienced dizziness and nausea. Since the vaccination the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events dizziness and nausea was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Blisters; Sore Throat; Fever of 102+; This case was reported by a consumer and described the occurrence of blister in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in April 2019, 6 months before the 2nd dose almost exactly, 6 months apart).   On 27th September 2019, the patient received the 2nd dose of Shingrix. In October 2019, 30 days after receiving Shingrix, the patient experienced blister, sore throat and fever. On an unknown date, the outcome of the blister, sore throat and fever were unknown.   It was unknown if the reporter considered the blister, sore throat and fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The month before the reporting date, the patient received second Shingrix vaccine shot. The patient experienced few blisters and had a fever of more than 102 degree F for a couple days. The patient had been fine ever since the shot. On 27th September 2019, the patient experienced no side effects after the shot. The patient asked wheher roughly a month after the second shot, could this be a side effect. The patient was on his way to the doctor, so if they call he could talk briefly. The patient asked do the side effects occur fairly soon, or could they occur a month later. The patient asked if it was a side effect, is it contagious adn could he spread something to others. The patient was going to a gathering with 100 people this w/e and did not want to spread anything. The patient reported that he had a sore throat. The patient asked whether the side effect were contagious. The patient was not 100 percent  sure this was a side effect.  The patient had zero problems since his first and second shot. A few days ago the patient got a fever, and then 2 blisters on his face, one inside a nostril, and now it appears he had some on my fingers. At first he thought it was a cooking burn, but both hands have one blister, one on my left ring finger and the other on my right thumb.      Lab Comments: On an unknown date the patient's body temperature was recorded as 102+ degree F.
Day #2 RA at Varicella admin. site turned "red" - raised slightly - warm to touch - abt size of 50 cent piece - Mom is a RN - admin. TYLENOL & compresses. No other symptoms reported.
4/1/2021, rash started on lower legs and upper thighs, feet; moved to arms, hands, and lower back. Extreme itching resulted in redness/brownness, large swollen blisters in patches and blistering with oily/bloody exudates over feet, thighs, hands, arms, chin, ear lobes. Treated initially by dermatologist with betametasone USP 0.10% bidx6weeks and tapered off lamotrigine.  Switched to augmented betametasone 0.05% 6/25/21, resulted in increased redness, inflammation, blistering, itching and pain.  Started Prednisone 10mg qd for 4 days with slight improvement then stopped without taper.  Started desoximetasone with slight improvement with Triamcinolone acetaonide cream and neosporin.  Started Prednisone 20 mg qd as per dermatologist today. Continuing on betamethasone bid.  Still fighting full body rash, itching and redness.
15-year-old female brought in by mother presents to the clinic today for redness on arm. Mother states that the patient received the varicella vaccine yesterday. After vaccine, pt developed an area of redness and tenderness around injection site so mother decided to bring pt back to the clinic for medical evaluation. Denies previous hx of vaccine reactions. Denies f/c/ns, n/v, trouble breathing, SOB, CP. No other concerns.
Took vaccine, still got shingles/suspected vaccination failure; shingles/Took vaccine, still got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 25-Jul-2022 Reporter's comment: The case was received from the consumer via interactive digital media. The reporter reported that she personally knew 4 other people who took vaccine and still got shingles. The reporter stated that the vaccine was expensive and did not work. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available. The case is 1 of 5 linked cases, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR105917:Same reporter US-GLAXOSMITHKLINE-US2022AMR105921:Same reporter US-GSK-US2022AMR111698:Same reporter US-GSK-US2022AMR111697:Same reporter US-GSK-US2022AMR111696:Same reporter US-GSK-US2022AMR111699:Same reporter
Fever; headache; This is a spontaneous report from a contactable consumer or other non hcp. A 38-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single (age at vaccination 38-year-old) for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced fever and headache on an unspecified date. Description of Event: Fever, headache. 38-year-old male. The outcome for all events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age allergic to penicillin. On 14-MAY-2013 the patient was vaccinated with ZOSTAVAX lot # H021712, (subcutaneous, dose unknown) for vaccination. Concomitant therapies included acetaminophen, acetaminophen, VICODIN. The pharmacist reported that a patient developed an injection site reaction at the site of ZOSTAVAX vaccination, described as a red area, no rash. The patient sought medical attention (contacted the pharmacist) and received treatment with BENADRYL. No lab diagnostics were performed. The patient hadn't recovered from the event. Additional information is not expected.
pt recv vax;10 hr later,started v; T 101;apap given;emesis;became listless; mom took pt hosp;IV started & cont for 6 hr & released;felt better next day;
This spontaneous report was received from a pharmacist regarding a patient of unknown demographics. There was no information about concurrent condition and historical medication. A couple years ago, on an unknown date the patient was vaccinated with VAQTA dose 1. It was reported that the patient was unclear if the second dose in VAQTA immunization series was administered in 6 calendar months and may have been administered earlier than 6 months. No adverse event was reported. No concomitant medication was involved. The outcome of the event was unknown. No PQC (product quality complaint) was involved. Additional information has been requested.
This is a spontaneous report received from a contactable other HCP. A 64-year-old male patient received unknown dose number of BNT162B2 (Comirnaty, batch/lot# unknown), at the age of 64, 2021, 0.3mL, single dose, for COVID-19 immunisation; and received unknown dose number of  mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# unknown), 2021, 0.3mL, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient reported booster/immunization/product preparation error, onset 2021, with outcome of unknown. Described as "drew up 1.8mLs of the Moderna vaccine and used it as diluent in the COVID-19 adult formula vaccine vial." The lot number for BNT162B2 not provided and will be requested during follow-up.
lingering headache; fatigue; soreness around injection site; chills; fever; This is a spontaneous report from a contactable other hcp (patient). A 26-years-old non-pregnant female patient received second dose of bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number: EL8982 and Expiration date: unknown), via an unknown route of administration, in left arm on 03Feb2021 at 08:30 (at the age of 26-year-old) as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. Patient previously took bnt162b2, administered in left arm on 13Jan2021 at 09:45 (Lot number: EL8982) and experienced soreness around injection site. Patient did not receive any other vaccine within 4 weeks prior to the covid-19 vaccine. Prior to vaccination, patient was not diagnosed with covid-19. Patient has no allergies to medications, food or other products. Since the vaccination, patient has not been tested for COVID-19. On 03Feb2021 at 21:00, the patient experienced soreness around injection site, chills/fever approx. 12 hours post-injection. On 04Feb2021, the patient experienced lingering headache and fatigue even 24 hours post-injection. The case was assessed as non-serious by the reporter. Patient did not received treatment for events. Outcome of events was recovering.  Follow-up attempts are completed. No further information is expected. .
This is a spontaneous report from a contactable pharmacist (patient). A 44-year-old female patient received first dose of bnt162b2 ( COVID-19 VACCINE; lot EK9231, expiration date unspecified), via an unspecified route of administration on 08Jan2021 at single dose (left arm) for COVID-19 immunization. Medical history included mild sleep apnea. The patient had no known allergies. The patient was not pregnant. There were no concomitant medications. On 09Jan2021, the patient experienced injection site pain and arm soreness on day 1 and day 2, patient was also very tired on day 1. Patient also had occasional sneezing and mild headache since day 1. On day 2, energy level was back to normal. However, on 11Jan2021, on day 3, the patient started to develop occasional shortness of breath and continued today, day 7. The shortness of breath comes and goes. On 14Jan2021, on day 6, the patient experienced occasional coughing and continued today, day 7. Since the patient was working in a pharmacy, she cannot rule out if symptoms were from vaccine or Covid exposure, so patient decided to get Covid test done today, day 7. The patient had no treatment received for the events. The patient had no other vaccine in 4 weeks and no other medications in 2 weeks. Patient had no Covid prior vaccination and was Covid tested post vaccination. The patient underwent lab tests and procedures which included nasal swab with pending results on 14Jan2021. Outcome of events was not recovered.
Fever, got up to 102.8.  After I gave him some infant's Tylenol, it started dropping.
Hives, Rash that began on left arm at vaccination site and spread across chest, to right arm and down abdomen, even a bit on upper thighs. Lasted for over a week.
Started Sunday 02/20/2005 scattered red raised bumps on arms, upper torso, upper part of legs. Itch , hurt.
A pharmacist reported an occurrence of non-response to the hepatitis B vaccine recombinant (Engerix-B) immunization series in a 47-year-old female. Concurrent medical conditions included an allergy to penicillin. Concurrent medications were not provided. On 01/16/1998, the pt received a 6th injection of hepatitis B vaccine recombinant (Engerix-B). Sometime after the injections, the pharmacist reported that the pt "never seroconverted."
tingling and cold sensation along left jaw line.  The sensation began shortly after injection and has continued.  Events remain ongoing.
Information has been received from a registered nurse concerning a female office medical assistant who on 24-FEB-2009 was vaccinated IM with the first 0.5 mL dose PNEUMOVAX (661529/0868X). Concomitant therapy included birth control pills (unspecified), antidepressant (unspecified) and diuretic (unspecified). A few hours after receiving the vaccine, the patient developed high fever, swelling at the injection site on the left upper arm, left axillary nodes and body aches. The patient was advised to take ADVIL and BENADRYL. At the time of reporting the patient was recovering. It was reported that two other patients experienced the similar adverse events after being vaccinated with the same lot number of PNEUMOVAX. The physician returned the PNEUMOVAX. Additional information has been requested.
Expired Bexsero administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 17-year-old patient who received Men B NVS (Bexsero) (batch number A2X3Y, expiry date 28-FEB-2023) for prophylaxis.   On 03-MAR-2023, the patient received the 1st dose of Bexsero. On 03-MAR-2023, an unknown time after receiving Bexsero, the patient experienced expired vaccine used (Verbatim: Expired Bexsero administered). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 10-MAR-2023 The nurse reported that a dose of Bexsero was administered to a patient, but such dose had expired. The vaccine administration facility was the same as primary reporter. The reporter was consented to follow up. HCP asked the follow up by Safety team to be done via phone number. The patient received expired Bexsero, which led to expired vaccine used.
This case is linked to case number 2015SA007140 (same reporter and same patient). A 56-year-old female patient had received a dose of influenza vaccine (manufacturer unknown, batch number, dose number, route and site of administration were not reported) on an unspecified date. The patient's medical history and concomitant medications were not reported. On an unspecified date, after vaccination, the patient had low grade fever and sore throat. Laboratory investigations and corrective treatment were not reported. At the time of this report, the patient outcome was unknown. Documents held by sender: none.
my ears started feeling like they were stopped up and my nose started feeling stuffy.; nose started feeling stuffy; felt flushed; my face was red; what feels like my heart quivering for several seconds followed 3 or 4 times by very slight pain; what feels like my heart quivering for several seconds; This is a spontaneous report received from a contactable consumer (patient). A 72-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6206) at left arm on 08Mar2021 09:30 AM at single dose for COVID-19 immunization. Medical history included gastroesophageal reflux disease, osteoarthritis, nodules on thyroids and allergy to Aspartsme. No covid tested post vaccination. Patient was not pregnant at the time of vaccination. Concomitant medication included pantoprazole sodium sesquihydrate (PANTOPRAZOLE 40). the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient previously took Sulfanomide (Sulfa drugs) and had allergy (swelling), codeine and had allergy (nausea). The symptom that has made patient concerned enough to report the possibility of a side effect is: she had her shot this morning and between about 8:55 and 9:15 this evening she had 9 or 10 episodes of what feels like her heart quivering for several seconds followed 3 or 4 times by very slight pain, just below her right breast, she has never experienced such a thing before. (she took baby aspirin around 9:20 in case she was having some kind of heart thing). It's 9:45 pm, and the quivering episodes haven't happened for the last 30 minutes, so maybe they're all cleared up. Earlier, within 30 min of getting the vaccine, her ears started feeling like they were stopped up and her nose started feeling stuffy. Then as she was driving home she felt flushed and looked in the mirror and her face was red, she took one Sudafed in case it was allergies, and those symptoms improved quite a lot. Adverse event start date was 08Mar2021 10:00 AM. Since the vaccination, the patient has not been tested for COVID-19. Unknown if treatment received for ears started feeling like they were stopped up and nose started feeling stuffy. Outcome of what feels like my heart quivering for several seconds followed 3 or 4 times by very slight pain was recovered. Outcome of felt flushed and face was red was recovering and outcome of other events was unknown.   Information on Lot/Batch number was available. Additional information has been requested.
I received a flu vaccine and the Pfizer Bivalent COVID-19 booster on 9/29/2022. On 11/24/2022, I celebrated the November holiday with my family. On 11/25/2022, two members who were there tested positive for COVID-19. On 12/5/2022, I felt like I had a mild flu. The symptoms included body aches, weakness, tiredness, and a slight chest heaviness. I did not have a fever or any difficulty breathing, though. The symptoms lasted about 4 days. For about a week after the 4 days, I didn't have much exercise tolerance. I still have some intermittent congestion in the nose and throat, but it's nothing serious; I sometimes wake up with a stuffy nose. Otherwise, I feel normal now. I took a home antigen test on 12/5/2022 and got a positive result. I was prescribed PAXLOVID, which I took for the prescribed 5 days.